Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 2, 2012, Pages 171-178

  Korthuis, P Todd ^a   Fiellin, David A ^b   McGinnis, Kathleen A ^c   Skanderson, Melissa ^c   Justice, Amy C ^b,d   Gordon, Adam J ^c,e   Doebler, Donna Almario ^c,e   Asch, Steven M ^f   Fiellin, Lynn E ^b   Bryant, Kendall ^g   Gibert, Cynthia L ^c,h   Crystal, Stephen ⁱ   Goetz, Matthew Bidwell ^j   Rimland, David ^k   Rodriguez Barradas, Maria C ^l   Kraemer, Kevin L ^e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY   (United States)

^g NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^h GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

ⁱ RUTGERS UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

alcohol; health care; HIV; opioid related disorders; quality indicators; quality of health care

Indexed keywords

CENTRAL STIMULANT AGENT; ILLICIT DRUG; OPIATE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS CARE; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; ILLICIT DRUG USE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OPIATE ADDICTION; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF REPORT; UNHEALTHY ALCOHOL USE;

ADULT; ALCOHOLS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; VETERANS;

EID: 84867021166     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31826741aa     Document Type: Article

References (54)

1. Moore RD, Keruly JC, Gebo KA, et al. An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002. J Acquir Immune Defic Syndr. 2005;39:195-198.
2. Schackman BR, Gebo KA, Walensky RP, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44:990-997.
3. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:651-681.
4. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at: http://www.aidsinfo.nih. gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed December 16, 2011.
5. The White House Office of National AIDS Policy. National HIV AIDS strategy for the United States. Available at: http://aids.gov/fed-eral- resources/policies/national-hiv-aids-strategy/nhas.pdf. Accessed November 15, 2011.
6. Horberg MA, Aberg JA, Cheever LW, et al. Development of national and multiagency HIV care quality measures. Clin Infect Dis. 2010;51: 732-738.
7. Institute of Medicine. Measuring what matters: allocation, planning, and quality assessment for the Ryan White CARE Act. Available at: http://www.iom.edu/report.asp?id=16325. Accessed March 20, 2004.
8. Korthuis PT. Quality of HIV care within the Veterans Affairs Health System: a comparison using outcomes from the HIV cost and services utilization study. J Clin Outcomes Manage. 2004;11:765-774.
9. Korthuis PT, Fiellin DA, Fu R, et al. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of bupre-norphine. J Acquir Immune Defic Syndr. 2011;56(suppl 1):S83-S90.
10. Backus LI, Boothroyd DB, Phillips BR, et al. National quality forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experience. Arch Intern Med. 2010;170:1239-1246.
11. Azar MM, Springer SA, Meyer JP, et al. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112:178-193.
12. Samet JH, Horton NJ, Meli S, et al. Alcohol consumption and antiretro-viral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28:572-577.
13. Palepu A, Horton NJ, Tibbetts N, et al. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99:361-368.
14. Korthuis PT, Josephs JS, Fleishman JA, et al. Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. J Subst Abuse Treat. 2008;35:294-303.
15. Palepu A, Horton NJ, Tibbetts N, et al. Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems. Alcohol Clin Exp Res. 2005;29:389-394.
16. Horberg M, Hurley L, Towner W, et al. HIV quality performance measures in a large integrated health care system. Aids Patient Care STDS. 2011;25:21-28.
17. Jha AK, Perlin JB, Kizer KW, et al. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care [see comment]. N Engl J Med. 2003;348:2218-2227.
18. Conigliaro J, Justice AC, Gordon AJ, et al. Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: a conceptual model to guide the implementation of evidence-based interventions into practice. Med Care. 2006;44(8 suppl 2):S1-S6.
19. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care. 2006;44(8 suppl 2):S13-S24.
20. Gross PA, Asch SM, Kitahata MM, et al. Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus [erratum appears in Clin Infect Dis. 2000;30(5):841. Note: Bozzette SA (corrected to Bozzette SA)]. Clin Infect Dis. 2000;30.
21. Feussner JR, Kizer KW, Demakis JG. The Quality Enhancement Research Initiative (QUERI): from evidence to action. Med Care. 2000;38(6 suppl 1):I1-I6.
22. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States [see comment]. N Engl J Med. 2003;348:2635-2645.
23. Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158:1789-1795.
24. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005; 352:596-607.
25. Centers for Disease Control and Prevention. Core measures for HIV/STD risk behavior and prevention. Sexual Behavior and Drug Behavior Questions, Versions 4 and 5. Atlanta, GA: Centers for Disease Control and Prevention; 2002.
26. Green TC, Kershaw T, Lin H, et al. Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend. 2010;110:208-220.
27. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
28. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282:1737-1744.
29. Landon BE, Wilson IB, McInnes K, et al. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV study [see comment]. Ann Intern Med. 2004;140:887-896.
30. Clark RE, Weir S, Ouellette RA, et al. Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries. Med Care. 2009;47:545-552.
31. Kanwal F, Schnitzler MS, Bacon BR, et al. Quality of care in patients with chronic hepatitis C virus infection: a cohort study. Ann Intern Med. 2010;153:231-239.
32. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
33. Fiellin DA, O'Connor PG, Wang Y, et al. Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses. Alcohol Clin Exp Res. 2006;30:70-75.
34. Ding L, Landon BE, Wilson IB, et al. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med. 2005;165:618-623.
35. Wood E, Hogg RS, Yip B, et al. Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. AIDS. 2005;19:1189-1195.
36. Turner BJ, Laine C, Cosler L, et al. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18:248-257.
37. Turner BJ, Laine C, Yang CP, et al. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization. Clin Infect Dis. 2003;37:15.
38. Messeri PA, Abramson DM, Aidala AA, Lee F, Lee G. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care. 2002;14(S1):S15-S29.
39. Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729-736.
40. Palepu A, Raj A, Horton NJ, et al. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat. 2005;28:3-9.
41. Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006; 84:188-194.
42. Korthuis PT, Josephs JS, Fleishman JA, et al. Substance abuse treatment in HIV: the role of patient-provider discussions. J Subst Abuse Treat. 2008;35:294-303.
43. Andersen RM, Bozzette SA, Shapiro MF, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res. 2000;35:389-416.
44. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38: 96-103.
45. Douaihy A, Stowell K, Bui T, et al. HIV/AIDS and homelessness, part 1: background and barriers to care. AIDS Read. 2005;15:516.
46. Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34:1273-1302.
47. Bouhnik AD, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretro-viral therapy. Antivir Ther. 2005;10:53-61.
48. Pyne JM, Asch SM, Lincourt K, et al. Quality indicators for depression care in HIV patients. AIDS Care. 2008;20:1075-1083.
49. Pyne JM, Fortney JC, Curran GM, et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011;171:23-31.
50. Asch SM, Kerr EA, Keesey J, et al. Who is at greatest risk for receiving poor-quality health care? N Engl J Med. 2006;354:1147-1156.
51. Haskell SG, Ning Y, Krebs E, et al. Prevalence of painful musculoskel-etal conditions in female and male veterans in 7 years after return from deployment in Operation Enduring Freedom/Operation Iraqi Freedom. Clin J Pain. 2012;28:163-167.
52. Wright SM, Craig T, Campbell S, et al. Patient satisfaction of female and male users of Veterans Health Administration services. J Gen Intern Med. 2006;21(suppl 3):S26-S32.
53. Dobie DJ, Kivlahan DR, Maynard C, et al. Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment. Arch Intern Med. 2004;164: 394-400.
54. Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/nalox-one. J Acquir Immune Defic Syndr. 2011;56(suppl 1):S33-S38.